Icon Medisciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.10 M
as on 24-10-2024
- Satisfied Charges ₹ 1.20 M
as on 24-10-2024
- Revenue 12.40%
(FY 2023)
- Profit 11.23%
(FY 2023)
- Ebitda 18.14%
(FY 2023)
- Net Worth 18.44%
(FY 2023)
- Total Assets 12.24%
(FY 2023)
About Icon Medisciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.10 M. The company has closed loans amounting to ₹1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Chopde, Pushpa Chopde, Meherlal Joshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51109MH2010PTC206063
- Company No.
206063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2010
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Icon Medisciences Private Limited offer?
Icon Medisciences Private Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Icon Medisciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Chopde  | Director | 29-Jul-2010 | Current |
| Pushpa Chopde | Director | 29-Jul-2010 | Current |
| Meherlal Joshi | Director | 07-Dec-2011 | Current |
| Jaya Meherlal | Director | 19-Apr-2019 | Current |
Financial Performance of Icon Medisciences.
Icon Medisciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.4% increase. The company also saw a substantial improvement in profitability, with a 11.23% increase in profit. The company's net worth Soared by an impressive increase of 18.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Icon Medisciences?
In 2023, Icon Medisciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 15 Nov 2023 | ₹1.60 M | Open |
Idbi Bank Limited Creation Date: 10 Jun 2014 | ₹2.50 M | Open |
The Saraswat Co-Operative Bank Limited Creation Date: 13 Mar 2012 | ₹1.20 M | Satisfied |
How Many Employees Work at Icon Medisciences?
Unlock and access historical data on people associated with Icon Medisciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Icon Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icon Medisciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
